LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

Search

Axonics Inc

Fermé

Secteur Soins de santé

70.28 0.01

Résumé

Variation du prix de l'action

24h

Actuel

Min

70.2

Max

70.29

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+1.02 upside

Dividendes

By Dow Jones

Prochains Résultats

28 oct. 2024

Sentiment de l'Actualité

By Acuity

50%

50%

179 / 390 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Axonics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

8 janv. 2024, 16:21 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Axonics Shares Climb 20% After Acquisition by Boston Scientific

8 janv. 2024, 12:26 UTC

Acquisitions, Fusions, Rachats

Boston Scientific To Acquire Axonics For About $3.7 Billion

19 sept. 2024, 16:36 UTC

Market Talk

Medtronic Continues Patent Infringement Fight After Losing Lawsuit -- Market Talk

8 janv. 2024, 15:59 UTC

Acquisitions, Fusions, Rachats

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot' -- IBD

8 janv. 2024, 14:19 UTC

Acquisitions, Fusions, Rachats

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value -- IBD

8 janv. 2024, 13:18 UTC

Acquisitions, Fusions, Rachats

Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal. -- Barrons.com

8 janv. 2024, 12:12 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Acquisition Impact to GAAP EPS Expected to Be Less Accretive, or More Dilutive, Due to Amortization Expense and Acquisition-Related Net Charges >BSX

8 janv. 2024, 12:12 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Sees Acquisition Impact to Adj EPS Immaterial in 2024 and Accretive Thereafter >BSX

8 janv. 2024, 12:11 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Axonics' Rev Growth Profile Is Anticipated to Be Highly Accretive to BSX Urology Business in 2024 >BSX

8 janv. 2024, 12:11 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Axonics Expects to Deliver Net Rev of About $366 M in 2023 >BSX

8 janv. 2024, 12:11 UTC

Actualités
Acquisitions, Fusions, Rachats

Boston Scientific To Acquire Axonics For About $3.7 Bln

8 janv. 2024, 12:10 UTC

Acquisitions, Fusions, Rachats

Axonic's Stock Soars After Cash Buyout Deal With Boston Scientific Valued At $3.7 Billion -- MarketWatch

8 janv. 2024, 12:02 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Deal Reflects Equity Value of About $3.7B and Enterprise Value of About $3.4B

8 janv. 2024, 12:02 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Acquisition to Expand Urology Portfolio With Differentiated Technologies to Treat Urinary and Bowel Dysfunction >BSX

8 janv. 2024, 12:02 UTC

Acquisitions, Fusions, Rachats

Boston Scientific to Buy Axonics for $71 in Cash Per Share >BSX AXNX

8 janv. 2024, 12:01 UTC

Acquisitions, Fusions, Rachats

Axonics to Be Acquired for $71/Share; Closed Friday at $57.57 >BSX AXNX

8 janv. 2024, 12:01 UTC

Acquisitions, Fusions, Rachats

Axonics to Be Acquired by Boston Scientific for About $3.7 Billion >BSX AXNX

8 janv. 2024, 12:01 UTC

Acquisitions, Fusions, Rachats

Axonics to Be Acquired by Boston Scientific for $71/Share Cash >BSX AXNX

8 janv. 2024, 12:00 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Announces Agreement To Acquire Axonics, Inc. >BSX AXNX

8 janv. 2024, 12:00 UTC

Acquisitions, Fusions, Rachats

Axonics Announces Definitive Agreement To Be Acquired By Boston Scientific >AXNX BSX

Comparaison

Variation de prix

Axonics Inc prévision

Objectif de Prix

By TipRanks

1.02% hausse

Prévisions sur 12 Mois

Moyen 71 USD  1.02%

Haut 71 USD

Bas 71 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

3 ratings

0

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

70.195 / 70.3Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

179 / 390Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

$